Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 28.00 (9.33%)
Spread: 4.50 (1.382%)
Open: 304.00
High: 350.00
Low: 303.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

Fri, 16th Apr 2021 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

----------

FTSE 100

----------

GOLDMAN SACHS RAISES EXPERIAN TO 'BUY' ('NEUTRAL') - TARGET 3,250 (3,000) PENCE

----------

UBS RAISES MONDI PRICE TARGET TO 2,160 (2,070) PENCE - 'BUY'

----------

JPMORGAN RAISES BT GROUP PRICE TARGET TO 230 (175) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES ENTAIN PRICE TARGET TO 1,872 (1,647) PENCE - 'BUY'

----------

BERENBERG RAISES HALMA PRICE TARGET TO 2,385 (2,310) PENCE - 'HOLD'

----------

JPMORGAN RAISES BT GROUP PRICE TARGET TO 230 (175) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES BP TO 'BUY' ('HOLD') - PRICE TARGET 355 PENCE

----------

CREDIT SUISSE RAISES TESCO PRICE TARGET TO 283 (280) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

RBC CUTS DIXONS CARPHONE TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 150 PENCE

----------

RBC RAISES WH SMITH TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 2,200 (2,100) PENCE

----------

MORGAN STANLEY RAISES BABCOCK INTERNATIONAL PRICE TARGET TO 260 (240) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,300 (1,280) PENCE - 'BUY'

----------

JPMORGAN RAISES MAN GROUP PRICE TARGET TO 185 (180) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES TRAVIS PERKINS PRICE TARGET TO 1,949 (1,900) PENCE - 'BUY'

----------

BERENBERG RAISES TRAVIS PERKINS PRICE TARGET TO 1,949 (1,900) PENCE - 'BUY'

----------

PEEL HUNT CUTS SPECTRIS TO 'ADD' ('BUY')

----------

BERENBERG RAISES SPECTRIS PRICE TARGET TO 3,640 (3,505) PENCE - 'BUY'

----------

BERENBERG RAISES OXFORD INSTRUMENTS PRICE TARGET TO 2,465 (2,300) PENCE - 'BUY'

----------

RBC RAISES BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 400 (385) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 405 (415) PENCE - 'UNDERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

CREDIT SUISSE RAISES ROBERT WALTERS PRICE TARGET TO 650 (530) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES THG PRICE TARGET TO 1,000 (885) PENCE - 'BUY'

----------

BERENBERG INITIATES BEGBIES TRAYNOR WITH 'BUY' - TARGET 155 PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Apr 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Apr 2021 08:19

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Read more
6 Apr 2021 08:08

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.

Read more
6 Apr 2021 07:53

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

Read more
21 Mar 2021 20:57

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe

By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, an EU official said on Sunday.Former EU member Britain ha...

Read more
19 Mar 2021 10:29

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Read more
19 Mar 2021 07:50

Oxford Biomedica says Sanofi pulling out of haemophilia project

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.

Read more
3 Feb 2021 13:56

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

Read more
29 Jan 2021 09:11

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots

* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses produced there (Adds detail, background)By Francesco Guarascio and Sabine SieboldBRUSSELS, Jan 29 (Re...

Read more
18 Jan 2021 17:18

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

Read more
8 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.